Buy Avastin from Canada
Avastin
From$799
$849
Avastin Bevacizumab
Select product strength & quantity:
Avastin Bevacizumab
Select product strength & quantity:
Prescription Required
Ships within 4-10 Business Days
Express Ships from Canada
Cold Shipment

What is Avastin?

Avastin, known generically as bevacizumab, is a significant pharmaceutical advancement in the treatment of various cancers. It is a monoclonal antibody that interferes with the growth and spread of cancer cells in the body. Avastin is primarily used in the treatment of certain types of cancers, including brain, lung, colon, kidney, and ovarian cancers. Additionally, although not FDA-approved for ophthalmic indications, Avastin is widely used off-label for wet age-related macular degeneration (AMD) due to its VEGF-inhibiting properties and lower cost compared with FDA-approved alternatives such as ranibizumab and aflibercept.

Its Role in Cancer Treatment and Macular Degeneration

In cancer treatment, Avastin is used to inhibit the growth of new blood vessels that tumors need to grow and spread. This process, known as antiangiogenesis, effectively starves the tumor of the necessary nutrients and oxygen. For macular degeneration, Avastin, though used off-label, helps in reducing the abnormal growth of blood vessels in the eye, which is a key factor in the progression of the disease.

Generic Name and Pronunciation

The generic name for Avastin is bevacizumab (pronounced bev-a-SIZ-oo-mab).

Description as an Antiangiogenic Agent

Avastin is classified as an antiangiogenic agent and an antineoplastic agent. It is specifically designed to bind to and inhibit a protein known as vascular endothelial growth factor (VEGF), which plays a crucial role in the formation of new blood vessels.

Mechanism of Action: How It Works by Inhibiting VEGF

Avastin’s mechanism of action involves the inhibition of VEGF. By binding to VEGF, Avastin prevents the interaction of VEGF with its receptors on the surface of blood vessel cells. This inhibition stops the formation of new blood vessels, cutting off the supply of oxygen and nutrients to tumors, thereby inhibiting tumor growth.

Medical Uses

Detailed List of Conditions Treated by Avastin

Brain Cancer (Glioblastoma)

Avastin is used in the treatment of recurrent glioblastoma, a type of aggressive brain cancer. It is often used when standard therapy has not been effective.

Cervical Cancer

Avastin is used in combination with chemotherapy for the treatment of persistent, recurrent, or metastatic cervical cancer.

Colon or Rectal Cancer (Colorectal Cancer)

Avastin is approved for the treatment of metastatic colorectal cancer, typically in combination with chemotherapy.

Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

It is used to treat advanced stages of ovarian, fallopian tube, or primary peritoneal cancer, often in conjunction with chemotherapy.

Kidney Cancer (Renal Cell Carcinoma)

Avastin, combined with interferon alfa, is used in the treatment of metastatic renal cell carcinoma.

Liver Cancer (Hepatocellular Carcinoma)

For the treatment of unresectable or metastatic hepatocellular carcinoma, Avastin is used in combination with atezolizumab.

Lung Cancer (Non-Squamous Non-Small Cell Lung Cancer)

Avastin is indicated for the first-line treatment of patients with unresectable, locally advanced, recurrent, or metastatic non-squamous non-small cell lung cancer, in combination with chemotherapy.

Off-Label Use for Wet Age-Related Macular Degeneration

Although not FDA-approved for this indication, Avastin is commonly used off-label to treat wet age-related macular degeneration by inhibiting abnormal blood vessel growth in the eye.

Dosage and Administration

Dosage Forms

  • Avastin is administered as an intravenous (IV) infusion.
  • It is not available in oral or injectable forms for patients to administer themselves.

Recommended Dosages for Different Conditions

  • Glioblastoma: The typical dose is 10 mg/kg every two weeks.
  • Metastatic Colorectal Cancer: 5 mg/kg every two weeks or 10 mg/kg every two weeks, depending on the treatment regimen.
  • Non-Squamous Non-Small Cell Lung Cancer: 15 mg/kg every three weeks in combination with chemotherapy.
  • Metastatic Renal Cell Carcinoma: 10 mg/kg every two weeks in combination with interferon alfa.
  • Persistent, Recurrent, or Metastatic Cervical Cancer: 15 mg/kg every three weeks in combination with chemotherapy.
  • Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: 15 mg/kg every three weeks as part of a combination therapy.
  • Hepatocellular Carcinoma: 15 mg/kg every three weeks in combination with atezolizumab.

Instructions for Administration and Frequency of Doses

  • Avastin infusions are administered by a healthcare professional in a clinical setting.
  • The first dose is usually given over 90 minutes. If well-tolerated, subsequent doses may be given over a shorter period (30 to 60 minutes).
  • The frequency of doses varies based on the condition being treated and the patient’s response to therapy.

Side Effects

Common Side Effects

  • Nosebleeds, headaches, high blood pressure, and rhinitis.
  • Other side effects include proteinuria, taste alteration, dry skin, and back pain.
  • Some patients may experience minor bleeding or gastrointestinal discomfort.

Serious Side Effects and Allergic Reactions

  • Severe side effects include gastrointestinal perforation, wound healing complications, and severe bleeding.
  • Infusion reactions, which can be severe, include difficulty breathing, chest pain, and severe headaches.
  • Allergic reactions may manifest as skin rashes, itching, or anaphylaxis in rare cases.

Long-term Risks

  • Potential for kidney problems, including proteinuria and nephrotic syndrome.
  • Increased risk of developing high blood pressure.
  • Increased risk of arterial and venous thromboembolic events.

Warnings and Precautions

Risks Associated with Avastin

  • Increased risk of gastrointestinal perforations and bleeding events.
  • Risk of impaired wound healing and surgery complications.
  • Potential for reversible posterior leukoencephalopathy syndrome (RPLS),  characterized by seizures, headache, visual disturbances, and altered mental status.

Conditions Under Which Avastin Should Not Be Used

  • Avastin should not be used in patients with hypersensitivity to bevacizumab or any of its components.
  • It is not recommended for patients with serious hemorrhage or a recent history of hemoptysis.
  • Avastin should be avoided in patients with uncontrolled hypertension or congestive heart failure.

Necessary Medical Tests Before and During Treatment

  • Regular monitoring of blood pressure and urine protein levels.
  • Assessment for signs of bleeding or thromboembolic events.
  • Monitoring for signs of infusion reactions during and after the administration of Avastin.

Interactions with Other Medications

Information on Drug Interactions

  • Avastin can interact with various medications, potentially altering its effectiveness or increasing side effects.
  • It is crucial to inform healthcare providers about all medications being taken, including over-the-counter drugs, prescriptions, and supplements.

Special Considerations for Use with Chemotherapy Drugs

  • Avastin is often used in combination with chemotherapy drugs. However, it can enhance the toxic effects of chemotherapy, particularly those related to bleeding and gastrointestinal perforation.
  • The use of Avastin with certain chemotherapy agents, such as anthracyclines, may increase the risk of congestive heart failure.
  • Coordination between healthcare providers is essential to manage the timing and dosage of Avastin and chemotherapy drugs to minimize risks.

Use in Specific Populations

Considerations for Use in Children

  • The safety and effectiveness of Avastin in pediatric patients have not been established.
  • Clinical trials in children have shown unique risks, such as abnormal growth of bones and tissues.

Considerations for Use in the Elderly

  • Elderly patients may have an increased risk of certain side effects, including arterial thromboembolic events.
  • Dosing may need to be adjusted based on the patient’s overall health and other existing medical conditions.

Considerations for Use in Pregnant or Breastfeeding Women

  • Avastin can cause harm to a developing fetus and should not be used during pregnancy.
  • Women of childbearing potential should use effective contraception during treatment and for a period after the end of treatment.
  • It is not recommended for breastfeeding women due to the potential for adverse effects in the nursing infant.
  • Due to the potential for serious adverse reactions in nursing infants and the long half-life of bevacizumab (approximately 20 days), breastfeeding is not recommended during treatment and for at least 6 months after the final dose.

Storage and Handling

Proper Storage Conditions

  • Avastin vials should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F).
  • The medication should be protected from light and not frozen.
  • Once prepared, the infusion solution can be stored for a limited time under specific conditions as outlined in the product labeling.

Handling and Disposal of the Medication

  • Avastin should be handled with care, and preparation should be done using aseptic techniques.
  • Any unused or expired Avastin should be disposed of properly, following guidelines for hazardous medications.
  • Needles, syringes, and materials used to prepare and administer Avastin should be placed in puncture-resistant containers and disposed of according to local regulations for biomedical waste.

Frequently Asked Questions

Avastin (bevacizumab) is primarily used to treat various types of cancer, including colorectal, lung, brain (glioblastoma), kidney, cervical, ovarian, and fallopian tube cancers. It works by inhibiting the growth of blood vessels that feed tumors, effectively starving them of the nutrients needed for growth. This mechanism, known as antiangiogenesis, is crucial in slowing down the progression of these cancers.

Avastin is administered through an intravenous (IV) infusion by a healthcare professional, typically in a hospital or clinical setting. The infusion process can take from 30 minutes to 90 minutes, depending on the dosage and the patient’s response to the first infusion. Avastin is not available in oral or self-injectable forms.

Common side effects of Avastin include nosebleeds, headaches, high blood pressure, and rhinitis. Patients may also experience proteinuria, taste alteration, dry skin, back pain, and minor bleeding. These side effects are usually manageable and may decrease in intensity as the body adjusts to the treatment.

Avastin is not recommended during pregnancy as it can harm the developing fetus. Women of childbearing age should use effective contraception during treatment and for a period after the end of treatment. If pregnancy occurs while taking Avastin, patients should immediately consult their healthcare provider.

The safety and effectiveness of Avastin in pediatric patients have not been established. Clinical trials in children have shown unique risks, such as abnormal growth of bones and tissues. Therefore, its use in children is generally not recommended unless part of a clinical trial or special program.

Avastin works by targeting and inhibiting a protein called vascular endothelial growth factor (VEGF). VEGF plays a key role in angiogenesis, the process of forming new blood vessels. By blocking VEGF, Avastin prevents the tumor from developing new blood vessels, thereby depriving it of the nutrients and oxygen needed to grow and spread.

Yes, Avastin is often used in combination with chemotherapy. This combination can enhance the effectiveness of treatment by attacking the cancer cells in different ways. However, it’s important to be aware that combining Avastin with certain chemotherapy drugs can increase the risk of side effects like bleeding and gastrointestinal perforation.

If you experience side effects from Avastin, contact your healthcare provider. They can provide advice on managing the side effects or adjusting your treatment plan if necessary. In the case of severe side effects, such as significant bleeding or signs of an allergic reaction, seek immediate medical attention.

The duration of Avastin treatment varies depending on the type of cancer, the stage of the disease, and the patient’s response to therapy. Some patients may receive Avastin as part of a short-term treatment plan, while others may continue on Avastin for an extended period.

Avastin is not a cure for cancer, but it can be an effective part of a treatment plan to control tumor growth and spread. It is used to improve survival rates and quality of life for patients with certain types of cancer.

As of my last update, biosimilar versions of Avastin are available. Biosimilars are similar to the original biologic medication and are expected to have the same safety and effectiveness.

Risks of using Avastin include serious side effects like gastrointestinal perforation, severe bleeding, wound healing complications, and increased risk of arterial and venous thromboembolic events. It’s important to discuss these risks with your healthcare provider before starting treatment.

Yes, Avastin can cause allergic reactions, though this is rare. Symptoms may include skin rashes, itching, or anaphylaxis. If you experience these symptoms, seek immediate medical attention.

There are no specific dietary restrictions while taking Avastin, but it’s always wise to maintain a balanced diet. Discuss with your healthcare provider for personalized dietary advice.

Some medications can interact with Avastin, so it’s important to inform your healthcare provider about all medications you’re taking. This includes over-the-counter drugs, prescriptions, and supplements.

Avastin should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen and should be protected from light. Once prepared, the infusion solution can be stored for a limited time under specific conditions.

If you miss a scheduled dose of Avastin, contact your healthcare provider as soon as possible to reschedule. It’s important to maintain a consistent treatment schedule for the best outcomes.

Elderly patients can use Avastin, but they may be at higher risk for certain side effects. It’s important for elderly patients to be closely monitored by their healthcare providers while on Avastin therapy.

Avastin is used off-label for the treatment of wet age-related macular degeneration. This use is not FDA-approved, but Avastin has been found effective in reducing abnormal blood vessel growth in the eye associated with this condition.

In case of an Avastin overdose, seek immediate medical attention. Overdose symptoms may not be immediately apparent, so it’s important to inform healthcare providers about the potential overdose for appropriate monitoring and treatment.

Disclaimer

Pharma Giant provides medical information to help you better understand medications and medical conditions.This content is for informational use only and does not replace advice from a licensed medical practitioner. Consult your doctor or pharmacist before starting or changing any medication. All our partners follow strict safety standards set by their country’s health authorities to make sure you receive safe and high-quality medications.

Have a prescription?

Order Avastin online today and enjoy a host of benefits, including:

 Customer Reviews
  • Cost Savings: Buy Avastin at LOWER PRICES compared to the US
  • Bulk Order Discounts: Enjoy additional savings with bulk orders of Avastin (up to 90-day supply)
  • Reliable Express Shipping: Fast and discreet delivery shipped directly to your doorstep
  • Exceptional Customer Service: Have a question? We’re delighted to help via live chat, email, or phone
  • Easy & Secure Ordering: Seamless online or phone ordering at 1-888-513-2294
  • SAVE 10% on first order with coupon code: PGSAVE10

Price Match Guarantee

Price Match Guarantee

We are committed to providing fair, competitive pricing on all medications. If you find a lower price on the same product at another verified Canadian online pharmacy, we’ll match it.

Eligibility Criteria

  • The pharmacy must be a licensed Canadian online pharmacy with a verifiable address.
  • The competitor’s price must be current and active (not from a past or future promotion).
  • The product must be identical in strength, pack size, quantity, manufacturer, and country of origin.
  • Requests must be submitted before placing an order — adjustments cannot be made after purchase.
  • Price matching does not apply to used or expired products.
  • Requests can be submitted via live chat or phone prior to completing your order.

Note: Price matching does not currently apply to Mounjaro® , Ozempic® or Saxenda®. However, this policy may be updated in the future.
Kenneth Fill, PharmD, MBA Fill

Kenneth Fill, PharmD, MBA, is a clinical pharmacist specialist and medical writer with a strong background in ambulatory care, pharmacogenomics, and medical content development. Based in the state of Michigan, he provides expert guidance on chronic disease state management. Kenneth completed his PharmD and MBA at the University of Toledo and pursued post-graduate residency training in ambulatory care and community-based pharmacy. His diverse background also includes academic detailing, clinical education, and interdisciplinary collaboration to enhance patient outcomes.